Skip to content

Development and Evaluation of an Evidence-based Education Program for People With Hand Dysfunction in Scleroderma

Development and Evaluation of an Evidence-based Education Program for People With Hand Dysfunction in Scleroderma: A Randomized Control Trail

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06697561
Enrollment
40
Registered
2024-11-20
Start date
2024-07-30
Completion date
2025-07-31
Last updated
2024-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scleroderma, Systemic

Keywords

Scleroderma, Hand dysfunction, Evidence-based knowledge translation, Patient education

Brief summary

The purpose of this study is to develop an evidence-based educational program for scleroderma patients with hand dysfunction. The program includes a self-care handbook and multimedia video resources. The study aims to answer: Does the intervention improve hand function in the experimental group compared to the control group? Does the intervention improve self-care knowledge of hand dysfunction? Does the intervention improve overall health? Participants will receive an 8-week program, while the control group receives usual care. Outcome measures include hand function, overall health, and self-care knowledge.

Detailed description

The study will adopt a repeated measures randomized controlled trial design (parallel randomized controlled trial) using convenience sampling. Participants in the experimental group will receive an evidence-based scleroderma hand dysfunction education program provided by the researchers for eight weeks. The control group will receive standard medical care during the study period and will receive the same scleroderma hand dysfunction education program as the experimental group after the study concludes. Both groups will undergo pre-intervention assessments, as well as post-intervention assessments at the fourth and eighth weeks. The primary outcome measures include evaluating the effectiveness of the education program in improving hand dysfunction severity, overall health, adherence to rehabilitation exercises, and self-care knowledge related to hand dysfunction.

Interventions

The intervention for the experimental group was an evidence-based educational program for hand dysfunction in patients with systemic sclerosis, which included a health education manual and multimedia videos developed through evidence translation. Additionally, individual education and consultation were provided.

Sponsors

Cheng Hsin Rehabilitation Medical Center
CollaboratorOTHER
National Taipei University of Nursing and Health Sciences
CollaboratorOTHER
Wen-Shao Lin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Participants with systemic sclerosis who meet the 2013 American College of Rheumatology (ACR) / European League Against Rheumatism (EULAR) diagnostic criteria and have hand dysfunction. 2. Adults aged 18 years or older. 3. Participants who are conscious and able to communicate in Mandarin Chinese or Taiwanese Hokkien. 4. Participants who provide informed consent to participate in the study after being briefed on its purpose.

Exclusion criteria

1\. Participants who have participated in any other hand rehabilitation program within the past three months. 2, Participants with organic brain dysfunction. 3. Participants with severe visual or hearing impairments. 4. Participants with serious illnesses that hinder communication or interfere with the normal learning process.

Design outcomes

Primary

MeasureTime frameDescription
Grip strengthAt baseline, 4 weeks, and 8 weeks post-intervention.Grip strength of the dominant hand (in kg) will be measured using a dynamometer, and the average of three trials will be used as the final muscle strength assessment indicator.
Raynaud's phenomenon visual analog scaleAt baseline, 4 weeks, and 8 weeks post-intervention.This scale evaluates the severity and impact of Raynaud's phenomenon on daily activities in patients with scleroderma over the past week. Scores range from 0 mm (no impact) to 100 mm (very severe impact), with higher scores indicating greater impairment of hand function
Digital ulcers visual analog scaleAt baseline, 4 weeks, and 8 weeks post-intervention.This scale evaluates the severity and impact of Digital ulcers on daily activities in patients with scleroderma over the past week. Scores range from 0 mm (no impact) to 100 mm (very severe impact), with higher scores indicating greater impairment of hand function.
Self-developed questionnaire on self-care knowledge for scleroderma hand dysfunctionAt baseline, 4 weeks, and 8 weeks post-interventionThe Scleroderma Hand Function-Related Self-Care Knowledge Scale, validated by experts for reliability and validity, consists of 15 items. The scale uses a dichotomous scoring method with three response options: True, False, and Don't know. It includes both positively and negatively worded items. Correct answers are scored as one point, while incorrect answers and Don't know responses are scored as zero. The total score ranges from 0 to 15, with higher scores indicating a greater level of self-care knowledge regarding scleroderma-related hand function impairments.
delta finger-to-palm, Delta-FTPAt baseline, 4 weeks, and 8 weeks post-intervention.Delta-FTP refers to the difference in distance between the tip of the third finger and the midpoint of the distal palmar crease when the finger is fully extended and fully flexed. It is an effective measurement method to assess the range of motion and flexibility of fingers in patients with scleroderma.

Secondary

MeasureTime frameDescription
Adherence to Hand Exercise TrainingAt baseline, 4 weeks, and 8 weeks post-intervention.Using an exercise diary as an evaluation tool to assess the effectiveness of adherence to rehabilitation exercise training
Overall disease severity visual analog scaleAt baseline, 4 weeks, and 8 weeks post-interventionThis scale measures the patient's self-assessed overall disease severity, ranging from 0 to 100, where 0 indicates the best health and 100 indicates the worst health, with higher scores indicating poorer overall health status.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026